Preferential tumour accumulation of gold nanoparticles, visualised by magnetic resonance imaging: Radiosensitisation studies invivo and invitro

International Journal of Radiation Biology

Volumn 86, Issue 8, 2010, Pages 692-700

  Hébert, Etienne M ^a,b   Debouttire, Pierre Jean ^a,b   Lepage, Martin ^a,c   Sanche, Léon ^a,b   Hunting, Darel J ^a,b  

^a Department of Nuclear Medicine and Radiobiology ^*  (Canada)

^b Centre for Radiotherapy Research (CR2)   (Canada)

^c UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

chemotherapeutic effect; gold nanoparticles; Kaplan Meier; low energy electrons; MRI contrast agents; radiosensitisers

Indexed keywords

GADOLINIUM PENTETATE; GOLD NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIZATION; TUMOR CELL; X RAY;

ANIMALS; CELL LINE, TUMOR; FEMALE; GADOLINIUM DTPA; GOLD; MAGNETIC RESONANCE IMAGING; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; NANOPARTICLES; RADIATION-SENSITIZING AGENTS;

MUS;

EID: 77955170094     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.3109/09553001003746067     Document Type: Article

References (37)

1. Abraham GE, Himmel PB. 1997. Management of rheumatoid arthritis: Rationale for the use of colloidal metallic gold. Journal of Nutritional & Environmental Medicine 7:295-305.
2. Alric CA, Serduc R, Le Duc C, Le Meur-Herland A, Billotey C, Perriat P, Roux S, Tillement O. 2008a. Gold nanoparticles designed for combining dual modality imaging and radiotherapy. Gold Bulletin 41:90-97.
3. Alric C, Taleb J, Le Duc G, Mandon C, Billotey C, Le Meur- Herland A, Brochard T, Vocanson F, Janier M, Perriat P, Roux S, Tillement O. 2008b. Gadolinium chelate coated gold nanoparticles as contrast agents for both X-ray computed tomography and magnetic resonance imaging. Journal of the American Chemical Society 130:5908-5915.
4. Bland JM, Altman DG. 1998. Survival probabilities (the Kaplan- Meier method). British Medical Journal 317:1572.
5. Bland JM, Altman DG. 2004. The logrank test. British Medical Journal 328:1073-1074.
6. Boudaiffa B, Cloutier P, Hunting DJ, Huels MA, Sanche L. 2000. Resonant formation of DNA strand breaks by low-energy (3 to 20 eV) electrons.[Report]. Science 287:1658-1660.
7. Carter JD, Cheng NN, Qu Y, Suarez GD, Guo T. 2007. Nanoscale energy deposition by X-ray absorbing nanostructures. Journal of Physical Chemistry B 111:11622-11625.
8. Cho SH. 2005. Estimation of tumour dose enhancement due to gold nanoparticles during typical radiation treatments: A preliminary Monte Carlo study. Physics in Medicine and Biology 50:N163-173.
9. Debouttière PJ, Roux S, Vocanson F, Billotey C, Beuf O, Favre-Réguillon A, Lin Y, Pellet-Rostaing S, Lamartine R, Perriat P, Tillement O. 2006. Design of gold nanoparticles for magnetic resonance imaging. Advanced Functional Materials 16:2330-2339. (Pubitemid 46025997)
10. Dixit VM, Van den Bossche J, Sherman DM, Thompson DH, Andres RP. 2006. Synthesis and grafting of thioctic acid-PEGfolate conjugates onto Au nanoparticles for selective targeting of folate receptor-positive tumor cells. Bioconjugate Chemistry 17:603-609.
11. Doan T, Massarotti E. 2005. Rheumatoid arthritis: An overview of the new and emerging therapies. Journal of Clinical Pharmacology 45:751-762.
12. Dvorak HF, Nagy JA, Dvorak JT, Dvorak AM. 1988. Identification and characterization of the blood-vessels of solid tumors that are leaky to circulating macromolecules. American Journal of Pathology 133:95-109.
13. El-Sayed IH, Huang X, El-Sayed MA. 2005. Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: Applications in oral cancer. Nano Letters 5:829-834.
14. Forestier J. 1935. Rheumatoid arthritis and its treatment by gold salts. Journal of Laboratory and Clinical Medicine 20:827-840.
15. Franken NP, Rodermond HM, Stap J, Haveman J, van Bree C. 2006. Clonogenic assay of cells in vitro. Nature Protocols 1:2315-2319.
16. Grdina DJ, Murley JS, Kataoka Y. 2002. Radioprotectants: Current status and new directions. Oncology 63:2-10.
17. Hainfeld JF, Slatkin DN, Smilowitz HM. 2004. The use of gold nanoparticles to enhance radiotherapy in mice. Physics in Medicine and Biology 49:N309-315.
18. Hillyer JF, Albrecht RM. 2001. Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. Journal of Pharmaceutical Sciences 90:1927-1936.
19. Kassis AI. 2004. The amazing world of auger electrons. International Journal of Radiation Biology 11-12:789-803
20. Krpetic Z, Porta F, Scar̀ G. 2006. Selective entrance of gold nanoparticles into cancer cells. Gold Bulletin 39:66-68.
21. Lanari C, Luthy I, Lamb CA, Fabris V, Pagano E, Helguero LA, Sanjuan N, Merani S, Molinolo AA. 2001. Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: In vivo and in vitro effects of estrogens and progestins. Cancer Research 61:293-302.
22. Lizon C, Fritsch P. 1999. Chemical toxicity of some actinides and lanthanides towards alveolar macrophages: An in vitro study. International Journal of Radiation Biology 75:1459-1471.
23. Maeda H. 2001. The enhanced permeability and retention (EPR) effect in tumor vasculature: The key role of tumor-selective macromolecular drug targeting. Advances in Enzyme Regulation 41:189-207.
24. McMahon SJ, Mendenhall MH, Jain S, Currell F. 2008. Radiotherapy in the presence of contrast agents: A general figure of merit and its application to gold nanoparticles. Physics in Medicine and Biology 53:5635-5651.
25. Mukherjee P, Bhattacharya R, Wang P, Wang L, Basu S, Nagy JA, Atala A, Mukhopadhyay D, Soker S. 2005. Antiangiogenic properties of gold nanoparticles. Clinical Cancer Research 11:3530-3534.
26. Murry P, Baldock C. 2000. Research software for radiotherapy gel dosimetry. Australasian Physical & Engineering Sciences in Medicine 23:44-51.
27. Noh SM, Kim WK, Kim SJ, Kim JM, Baek KH, Oh YK. 2007. Enhanced cellular delivery and transfection efficiency of plasmid DNA using positively charged biocompatible colloidal gold nanoparticles. Biochimica et Biophysica Acta 1770:747-752.
28. Olfert ED, Cross BM, McWilliam AA. 1993. Guide to the care and use of experimental animals. Canadian Council on Animal Care.
29. Rockwell SC, Kallman RF, Fajardo LF. 1972. Characteristics of a serially transplanted mouse mammary tumor and its tissueculture- adapted derivative. Journal of the National Cancer Institute 49:735-749.
30. Sanche L. 2005. Low-energy electron-driven damage in biomolecules. The European Physical Journal D 35:367-390.
31. Tomayko MM, Reynolds CP. 1989. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemotherapy Pharmacology 24:148-154.
32. Wardman P. 2007. Chemical radiosensitizers for use in radiotherapy. Clinical Oncology 19:397-417.
33. Wollheim FA. 1998. Reumatoid arthritis - the clinical picture. In: Maddison PJ, Isenberg DA, Woo P, editors. Oxford textbook of rheumatology. 2nd ed. Oxford: Oxford University Press. pp 1004-1031.
34. Yang PH, Sun X, Chiu JF, Sun H, He QY. 2005. Transferrinmediated gold nanoparticle cellular uptake. Bioconjugate Chemistry 16:494-496.
35. Zheng S, Newton GL, Gonick G, Fahey RC, Ward JF. 1988. Radioprotection of DNA by thiols relationship between the net charge on a thiol and its ability to DNA. Radiation Research 114:11-27.
36. Zheng S, Newton GL, Gonick G, Ward JF, Fahey RC. 1992. Aerobic radioprotection of pBR322 by thiols: Effect of thiol net charge on scavenging of hydroxyl radicals and repair of DNA radicals. Radiation Research 130:183-193.
37. Zheng Y, Hunting DJ, Ayotte P, Sanche L. 2008. Radiosensitization of DNA by gold nanoparticles irradiated with high-energy electrons. Radiation Research 169:19-27.